674 related articles for article (PubMed ID: 15018213)
1. "Sufficiency" for living organism inventions under the Patents Act 1990 (Cth).
Lawson C
J Law Med; 2004 Feb; 11(3):373-81. PubMed ID: 15018213
[TBL] [Abstract][Full Text] [Related]
2. Patent first, ask questions later: morality and biotechnology in patent law.
Bagley MA
William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
[TBL] [Abstract][Full Text] [Related]
3. [Patents on life? No patent on life!].
van Raden L
Dtsch Tierarztl Wochenschr; 1998 Mar; 105(3):90-3. PubMed ID: 9581373
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic testing of genetic disorders: limiting the scope of patent claims through disclosure requirements.
Abbot J
J Law Med; 2006 Aug; 14(1):110-26. PubMed ID: 16937785
[TBL] [Abstract][Full Text] [Related]
5. European Directive on the Legal Protection of Biotechnological Inventions: scope, status and controversies in a nutshell.
Hakki MM
E Law; 2004 Mar; 11(1):E4. PubMed ID: 16903025
[No Abstract] [Full Text] [Related]
6. Clarification of the Australian Patent Office's implementation of the Budapest Treaty.
Kurts A
Australas Biotechnol; 1994; 4(5):278-9. PubMed ID: 7765673
[No Abstract] [Full Text] [Related]
7. Towards harmonization: the European biotechnology patent directive.
Curley D
J Biolaw Bus; 2002; 5(3):64-8. PubMed ID: 12816122
[TBL] [Abstract][Full Text] [Related]
8. Intellectual property protection for plant-related inventions in Europe.
Fleck B; Baldock C
Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
[TBL] [Abstract][Full Text] [Related]
9. The patentability of living organisms between science, law and ethics.
Frati L; Foà R; Frati P
Forum (Genova); 1999; 9(3 Suppl 3):8-14. PubMed ID: 10607843
[TBL] [Abstract][Full Text] [Related]
10. Biotech patents: the world is your oyster--or mouse--or (you name it).
Alix JE
Technol Health Care; 1996 Sep; 4(3):255-8. PubMed ID: 8931235
[TBL] [Abstract][Full Text] [Related]
11. Biomedical patents and ethics: a Canadian solution.
Gold ER
McGill Law J; 2000 May; 45(2):413-35. PubMed ID: 12688288
[TBL] [Abstract][Full Text] [Related]
12. [The generic Research and Development possibilities after Hungary accessed th European Patent Convention].
Kelen A; Angyal N; Máthé Z; Bódis A; Hódi K
Acta Pharm Hung; 2003; 73(2):123-9. PubMed ID: 14702693
[TBL] [Abstract][Full Text] [Related]
13. The ethics of biotechnology.
Lenoir N
J Biolaw Bus; 2001; 4(2):6-10. PubMed ID: 12530386
[TBL] [Abstract][Full Text] [Related]
14. Patents on parts of the human body: salient issues under EC and WTO law.
Herdegen M
J World Intellect Prop; 2002 Mar; 5(2):145-55. PubMed ID: 15986546
[No Abstract] [Full Text] [Related]
15. To patent or not to patent: the European Union's new biotech directive.
Nenow L
Houst J Int Law; 2001; 23(3):569-607. PubMed ID: 12769115
[No Abstract] [Full Text] [Related]
16. [Patent rights and biotechnological inventions].
Lobato García-Miján M
Rev Derecho Genoma Hum; 1998; (9):143-61. PubMed ID: 10335339
[TBL] [Abstract][Full Text] [Related]
17. Biotechnology patenting policy in the European Union--as exemplified by the development in Germany.
Schrell A; Bauser H; Brunner H
Adv Biochem Eng Biotechnol; 2007; 107():13-39. PubMed ID: 17522818
[TBL] [Abstract][Full Text] [Related]
18. Using the written description requirement to limit broad patent scope, allow competition, and encourage innovation in biotechnology.
Mull WC
Health Matrix Clevel; 2004; 14(2):393-435. PubMed ID: 15503695
[TBL] [Abstract][Full Text] [Related]
19. Patent protection for Aspergillus-related inventions.
Jong SC; Birmingham JM
Biotechnology; 1992; 23():297-311. PubMed ID: 1504603
[TBL] [Abstract][Full Text] [Related]
20. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents.
Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Beyer A; Visaria J
Food Drug Law J; 2009; 64(1):171-81. PubMed ID: 19998745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
